(SALT LAKE CITY)—The University of Utah College of Pharmacy's Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of ...
Since 1975, the ADD program has been testing and identifying antiseizure drugs for the nearly one-third of people with epilepsy that is refractory to current medications. The University of Utah ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback